An Ovine Model of Dilated Cardiomyopathy Induced by Doxorubicin
Background: Dilated cardiomyopathy is associated with a progressive deterioration in cardiac function and eventually death. Initial interest in this hypothesis was to create another large animal model for dilated cardiomyopathy in addition to pigs and dogs. Methods: After the induction of anesthesi...
| Published in: | Journal of Tehran University Heart Center |
|---|---|
| Main Authors: | Mahmood Mirhoseini, Shahram Rabbani, Sirus Darabian, Saeed Sadeghian, Abbasali Karimi, Seyed Hesameddin Abbasi |
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2007-10-01
|
| Subjects: | |
| Online Access: | https://jthc.tums.ac.ir/index.php/jthc/article/view/67 |
Similar Items
Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01)
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01)
Reversible dilative cardiomyopathy after electrical injury: a case report
by: Eirini Liodaki, et al.
Published: (2018-11-01)
by: Eirini Liodaki, et al.
Published: (2018-11-01)
Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
by: Gehan Abd El-Rahman El-Zarea, et al.
Published: (2016-02-01)
by: Gehan Abd El-Rahman El-Zarea, et al.
Published: (2016-02-01)
Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Ali Ghayemian, et al.
Published: (2007-08-01)
by: Ali Ghayemian, et al.
Published: (2007-08-01)
Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms
by: Jorge Berlanga-Acosta, et al.
Published: (2024-05-01)
by: Jorge Berlanga-Acosta, et al.
Published: (2024-05-01)
Dilated cardiomyopathy due to hypocalcaemia: a case report
by: Nilushka Rupasinghe, et al.
Published: (2024-04-01)
by: Nilushka Rupasinghe, et al.
Published: (2024-04-01)
Dilated cardiomyopathy and myocarditis: a clinical case
by: O.V. Onyshchenko, et al.
Published: (2023-12-01)
by: O.V. Onyshchenko, et al.
Published: (2023-12-01)
Factors affecting mortality in children with dilated cardiomyopathy
by: Muhammed Nurullah Sabaz, et al.
Published: (2019-08-01)
by: Muhammed Nurullah Sabaz, et al.
Published: (2019-08-01)
Idiopathic dilated cardiomyopathy in children: Prognostic indicators
by: Mehmet Emre Arı, et al.
Published: (2019-04-01)
by: Mehmet Emre Arı, et al.
Published: (2019-04-01)
Similar burden of rare genetic variants in ischemic and non-ischemic dilated cardiomyopathy
by: Louie Cao, et al.
Published: (2025-04-01)
by: Louie Cao, et al.
Published: (2025-04-01)
Peripartum dilated cardiomyopathy
by: Đorđević Spomenka, et al.
Published: (2011-01-01)
by: Đorđević Spomenka, et al.
Published: (2011-01-01)
Myocarditis and Inflammatory Cardiomyopathy in Dilated Heart Failure
by: Francesco Nappi
Published: (2025-03-01)
by: Francesco Nappi
Published: (2025-03-01)
Role of cardiac MRI in assessment of patients with dilated cardiomyopathy
by: Heba R. Ibrahim, et al.
Published: (2017-12-01)
by: Heba R. Ibrahim, et al.
Published: (2017-12-01)
Progress on the role of melatonin in dilated cardiomyopathy
by: LIU Jia, XU Kai, SHI Rui-zheng, ZHANG Guo-gang
Published: (2022-07-01)
by: LIU Jia, XU Kai, SHI Rui-zheng, ZHANG Guo-gang
Published: (2022-07-01)
MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
by: Enrica Chiti, et al.
Published: (2021-09-01)
by: Enrica Chiti, et al.
Published: (2021-09-01)
Multimodal characterization of dilated cardiomyopathy: Geno‐ And Phenotyping of PrImary Cardiomyopathy (GrAPHIC)
by: Laura Keil, et al.
Published: (2024-02-01)
by: Laura Keil, et al.
Published: (2024-02-01)
Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy
by: Yusheng Wang, et al.
Published: (2024-01-01)
by: Yusheng Wang, et al.
Published: (2024-01-01)
Modern View on the Dilated Cardiomyopathy
by: Yuzych I.
Published: (2014-06-01)
by: Yuzych I.
Published: (2014-06-01)
A case of dilated cardiomyopathy
by: Arvind Dambalkar
Published: (2017-01-01)
by: Arvind Dambalkar
Published: (2017-01-01)
Rare cause of cardioembolic stroke in former athlete with dilated cardiomyopathy
by: Cristina Laza, et al.
Published: (2012-09-01)
by: Cristina Laza, et al.
Published: (2012-09-01)
Dilated cardiomyopathy in hyperthyroidism can be reversed with treatment
by: Lama Alasmari, et al.
Published: (2023-01-01)
by: Lama Alasmari, et al.
Published: (2023-01-01)
A Case Report of Reversible Dilated Cardiomyopathy
by: Abhishek Singhai
Published: (2014-01-01)
by: Abhishek Singhai
Published: (2014-01-01)
Dilated cardiomyopathy and aldosteronoma: a causal link?
by: Jiyu Zhang, et al.
Published: (2020-02-01)
by: Jiyu Zhang, et al.
Published: (2020-02-01)
Decreased Aortic Elasticity in Noncompaction Cardiomyopathy Compared to Dilated Cardiomyopathy
by: Martijn Tukker, et al.
Published: (2025-08-01)
by: Martijn Tukker, et al.
Published: (2025-08-01)
Expression of interleukin 1, interleukin 27, and TNF α genes in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy: A case‐control study
by: Mahdiyar Iravani Saadi, et al.
Published: (2022-07-01)
by: Mahdiyar Iravani Saadi, et al.
Published: (2022-07-01)
Platelet aggregation activity and beta-adrenoblocker therapy in patients with dilated cardiomyopathy
by: P. N. Isakhanova, et al.
Published: (2012-02-01)
by: P. N. Isakhanova, et al.
Published: (2012-02-01)
Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
by: Hamza El Hadi, et al.
Published: (2023-02-01)
by: Hamza El Hadi, et al.
Published: (2023-02-01)
Epidemiology of cardiomyopathy - A clinical and genetic study of dilated cardiomyopathy: The EPOCH-D study
by: Soumi Das, et al.
Published: (2015-01-01)
by: Soumi Das, et al.
Published: (2015-01-01)
Doxorubicin-induced dilated cardiomyopathy for modified radical mastectomy: A case managed under cervical epidural anaesthesia
by: Anuj Jain, et al.
Published: (2013-01-01)
by: Anuj Jain, et al.
Published: (2013-01-01)
Genotype-phenotype insights of pediatric dilated cardiomyopathy
by: Ying Dai, et al.
Published: (2025-01-01)
by: Ying Dai, et al.
Published: (2025-01-01)
Doxorubicin induced reversible cardiomyopathy: A Case report
by: K Tamakuwala, et al.
Published: (2015-07-01)
by: K Tamakuwala, et al.
Published: (2015-07-01)
The inflammatory and nutritional status in patients with dilated cardiomyopathy: Different impact for distinct phenogroups?
by: Tobias Lerchner, et al.
Published: (2025-02-01)
by: Tobias Lerchner, et al.
Published: (2025-02-01)
A child with dilated cardiomyopathy and homozygous splice site variant in FLNC gene
by: Afaf Alsubhi, et al.
Published: (2024-03-01)
by: Afaf Alsubhi, et al.
Published: (2024-03-01)
Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results
by: Jiří Plášek, et al.
Published: (2024-01-01)
by: Jiří Plášek, et al.
Published: (2024-01-01)
Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy
by: Andrea Lalario, et al.
Published: (2022-10-01)
by: Andrea Lalario, et al.
Published: (2022-10-01)
The Molecular Role of Immune Cells in Dilated Cardiomyopathy
by: Enping Wang, et al.
Published: (2023-07-01)
by: Enping Wang, et al.
Published: (2023-07-01)
Adrenocortical carcinoma presenting as reversible dilated cardiomyopathy
by: Mansoor C Abdulla
Published: (2018-01-01)
by: Mansoor C Abdulla
Published: (2018-01-01)
Variants of RBM20 gene in pediatric patients with dilated cardiomyopathy
by: A. M. Kiselev, et al.
Published: (2019-11-01)
by: A. M. Kiselev, et al.
Published: (2019-11-01)
Expression of cardiac troponin I in dilated and ischemic cardiomyopathy and its clinical significance
by: Xian-Hua Li, et al.
Published: (2023-10-01)
by: Xian-Hua Li, et al.
Published: (2023-10-01)
Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
by: Megan J. Puckelwartz, et al.
Published: (2021-04-01)
by: Megan J. Puckelwartz, et al.
Published: (2021-04-01)
Similar Items
-
Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01) -
Reversible dilative cardiomyopathy after electrical injury: a case report
by: Eirini Liodaki, et al.
Published: (2018-11-01) -
Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
by: Gehan Abd El-Rahman El-Zarea, et al.
Published: (2016-02-01) -
Serum Zinc Level in Dilated and Ischemic Cardiomyopathy
by: Ali Ghayemian, et al.
Published: (2007-08-01) -
Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanisms
by: Jorge Berlanga-Acosta, et al.
Published: (2024-05-01)
